BioProtect develops novel biodegradable spacers for radiation oncology. The ProSpace™ System temporarily separates the rectum from prostate during radiotherapy for prostate cancer, reducing rectal dose. Following superior average spacing results in EU studies, the company launched a multi-center FDA pivotal study and is actively recruiting centers.
8 Tsor St.
Tzur Yigal, 4486200 Israel